Cargando…
Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID)
AIMS: An association between antibody deficiency and clozapine use in individuals with schizophrenia has recently been reported. We hypothesised that if clozapine-associated hypogammaglobulinaemia was clinically relevant this would manifest in referral patterns. METHODS: Retrospective case note revi...
Autores principales: | Ponsford, Mark James, Steven, Rachael, Bramhall, Kathyrn, Burgess, Mathew, Wijetilleka, Sonali, Carne, Emily, McGuire, Frances, Price, Colin R, Moody, Mo, Zouwail, Soha, Tahir, Tayyeb, Farewell, Daniel, El-Shanawany, Tariq, Jolles, Stephen R A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476264/ https://www.ncbi.nlm.nih.gov/pubmed/32094276 http://dx.doi.org/10.1136/jclinpath-2019-206235 |
Ejemplares similares
-
Clozapine is associated with secondary antibody deficiency
por: Ponsford, Mark, et al.
Publicado: (2019) -
COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort
por: Ponsford, Mark J., et al.
Publicado: (2022) -
Assessing Disease Severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-Like Disorders
por: Ameratunga, Rohan
Publicado: (2018) -
Editorial: Updates on the pathogenesis of common variable immunodeficiency (CVID)
por: Martelius, Timi, et al.
Publicado: (2023) -
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding
por: Morgan, Clare, et al.
Publicado: (2022)